Pancreatic Disorders & Therapy

Pancreatic Disorders & Therapy
Open Access

ISSN: 2165-7092

+44 1478 350008

Research Article - (2013) Volume 3, Issue 2

Gastric Varices Secondary to Splenic Vein Occlusion due to Pancreatic Diseases

Takahiro Sato*, Sho Kitagawa, Mutsuumi Kimura, Takumi Ohmura, Yoshiyasu Karino and Jouji Toyota
Department of Gastroenterology, Sapporo Kosei General Hospital, Japan
*Corresponding Author: Dr. Takahiro Sato, Department of Gastroenterology, Sapporo Kosei General Hospital, Kita 3 Higashi 8, Chuo-ku, Sapporo 060-0033, Japan, Tel: +81-11-261-5331, Fax: +81-11-261-6040 Email:

Abstract

Gastric varices that arise secondary to splenic vein occlusion can result in hypersplenism or gastrointestinal hemorrhaging. This article review gastric varices secondary to splenic vein occlusion due to pancreatic diseases with regard to causes of the condition, as well as diagnostic and therapeutic approaches. Diagnosis of gastric varices is made following esophago-gastro-duodenoscopy, and splenic vein occlusions are diagnosed from enhanced computed tomographic scans in almost all cases. Specific findings of gastric varices secondary to splenic vein occlusion are based on endoscopic ultrasonographic color flow images of gastric variceal flow that clearly depicted round cardiac and fundal regions at the center, with varices expanding to the curvatura ventriculi major of the gastric body. Several treatment options for gastric variceal bleeding secondary to splenic vein occlusion have been proposed. Splenectomy, which decompresses the short gastric vein by cutting off inflow, has generally been considered the best treatment of choice in such condition. Endoscopic injection sclerotherapy using cyanoacrylate, is useful in the treatment of bleeding gastric varices due to splenic vein occlusion. As patients with splenic vein occlusion have normal portal pressure and normal hepatic function, portal systemic shunting is not indicated. Splenic arterial embolization, which reduces blood flow through the splenic parenchyma, is another effective method of controlling bleeding from gastric varices secondary to splenic vein occlusion. Treatment of gastric varices secondary to splenic vein occlusion is directed to the underlying pancreatic diseases.

<

Keywords: Gastric varices; Splenic vein occlusion; Pancreatic disease endoscopic ultrasonography; Color doppler; Left-sided portal hypertension

Abbreviations

EGD: Esophago-Gastro-Duodenoscopy; EUS: Endoscopic Ultrasonography; ECDUS: Endoscopic Color Doppler Ultrasonography; ECDUS: Endoscopic Color Doppler Ultrasonography; CT: Computed Tomography; EIS: Endoscopic Injection Sclerotherapy

Introduction

Gastric variceal hemorrhage is a common complication of portal hypertension and is associated with higher rates of morbidity and mortality than hemorrhage of esophageal varices [1]. Although hemodynamic studies of gastric varices are employed worldwide [2-4], splenic vein occlusion is often clinically silent, presenting no obvious symptoms. However, gastric varices secondary to splenic vein occlusion can cause hypersplenism or gastrointestinal hemorrhaging (left-sided portal hypertension) [5-8].

In this article, we review the diagnostic and therapeutic approaches, for left-sided portal hypertension due to pancreatic diseases.

Pathophysiology/Symptoms of Left-sided Portal Hypertension

Splenic vein occlusion results in left-sided portal hypertension (characterized by gastric varices, splenomegaly and normal liver function) [9-11] that is secondary to various diseases [12-14]. The majority of splenic vein occlusions are the result of pancreatic diseases, including acute and chronic pancreatitis or pancreatic tumor. Bertina reported that Von Leiden factor (FVL) deficiency has been reported in 2% to 30% of patients with portal vein thrombosis [15]. Moreover, the other articles found that FVL deficiency was also highly associated with splenic vein thrombosis [16,17]. As other causes, advanced left renal cancer and myeloproliferative disease are recognized. There is a strong association between pancreatic diseases and splenic vein occlusion because of the splenic vein, s anatomy. Sutton et al. reported that 35% of their cases of isolated splenic vein occlusion were caused by tumors and only 17% by pancreatitis [9]. On the other hand, Sakorafas et al. found that pancreatitis was the etiology in 87 (60%) of 144 cases, while pancreatic malignancy was detected in only [13] (9%) of the patients [7], and recent reviews have clarified acute or chronic pancreatitis to be the probable cause of splenic vein thrombosis in the majority of cases [18]. There is a possible pathogenetic mechanism implying the increased intra-abdominal pressure leading to compression of the splenic vein in the case of pancreatic pseudocyst [19,20].

Due to splenic vein occlusion, splenic venous flow must drain into collateral veins (short gastric vein and left gastroepiploic vein). Then, the increased blood flow dilates the submucosal veins of stomach, resulting in gastric varices (Figure 1). Because blood drainage is diverted by the coronary vein into the patent portal system, the presence of gastric varices without esophageal varices is a very specific sign of splenic vein occlusion [17]. This condition, which is commonly silent clinically, can cause hypersplenism or gastrointestinal hemorrhage.

pancreatic-disorders-therapy-splenic-vein

Figure 1: Hemodynamics of splenic vein occlusion.

Although splenic vein occlusion is commonly silent clinically, this condition may cause hypersplenism or gastrointestinal bleeding due to gastric varices. In previous studies of splenic vein occlusion, gastrointestinal bleeding has been reported to occur in 16-78% of patients [8,9,13,21-24]. Sutton et al. [9] found 53 cases of such occlusion, and reported a 64% incidence of upper gastrointestinal bleeding. Itzchak and Glickman [24] noted gastrointestinal hemorrhaging in in only 3 of 19 patients with splenic vein occlusion. Sarin et al. [22] studied the prevalence of gastric varices in 568 patients with portal hypertension, and they reported that 7 of 9 patients (78%) with gastric varices due to splenic vein occlusion had a history of previous variceal bleeding. Due to recent improvements in cross-sectional imaging, Heider et al. reported gastric variceal bleeding from pancreatitis- induced splenic vein thrombosis (with minimal symptoms) in only 4% of patients [25].

Diagnosis of Gastric Varices Secondary to Left-sided Portal Hypertension

Gastric varices have been diagnosed by esophago-gastro-duodenoscopy (EGD), a useful modality for observing gastric varices of a certain size and extent (Figure 2). EGD is usually the initial investigation in patients with portal hypertension for the purpose of distinguishing between gastric varices and gastric folds, and it has a very sensitive predictive value for variceal hemorrhage [26]. However, there are few cases of red color-positive gastric varices and it is difficult to diagnose a high risk for bleeding of gastric varices. Still further, EGD is a limited modality for detecting gastric varices, given how deep the submucosal or extramural collateral veins of gastric varices are.

pancreatic-disorders-therapy-gastric-varices

Figure 2: Endoscopic findings are gastric varices secondary to splenic vein occlusion after acute pancreatitis.

Endoscopic ultrasonography (EUS) has become a useful modality for the diagnosis for esophagogastric varices, and it is considered most useful in evaluating gastric varices [27-29]. In a previous report, Sato et al. described the utility of endoscopic color Doppler ultrasonography (ECDUS) in patients with gastric varices [30]. Relative to EUS, ECDUS color images of blood flow in vessels allow for detailed sonographic visualization of vessels and evaluation of vascular blood flow for the diagnosis of gastric varices [31,32].

Endoscopic evidence is not sufficient to distinguish between gastric varices due to splenic vein occlusion or the gastric fold. Additional images resulting from ECDUS color analysis of gastric variceal flow clearly depicted a round fundal region at the center, with varices that expanded to the curvatura ventriculi major of the gastric body on gastric varices due to splenic vein occlusion (Figures 3a and 3b) [23]. Variceal location of ordinary gastric varices was classified as fundal (located far from the cardiac orifice) and cardiac and fundal (located between the cardiac orifice and the fundus), however, there was no case with varices expanding to the curvatura ventriculi major of the gastric body with ECDUS findings of ordinary gastric varices [30]. These data provide specific findings that can function as hallmarks of gastric varices due to splenic vein occlusion. The sensitivity of ECDUS in identifying gastric varices due to splenic vein occlusion should be considered for patients with high clinical suspicion [33].

pancreatic-disorders-therapy-Doppler-ultrasonography

Figure 3a: Endoscopic color Doppler ultrasonography color flow images of gastric variceal flow clearly depicted round cardiac and fundal regions at the center, with varices expanding to the curvatura ventriculi major of the gastric body.

pancreatic-disorders-therapy-Fast-Fourier

Figure 3b: Fast-Fourier transform analysis showed a continuous wave.

Percutaneous ultrasonographic examinations and color flow imaging are used as a preliminary, non-invasive method for splenic vein occlusion. However, those methods may be less accurate in assessing splenic vein patency because of the anatomic location of splenic vein, and in addition, may be unsuccessful when the acoustic window is not available for evaluation of whole portal venous system [34,35]. Contrast-enhanced computerized tomography (CT) portography can demonstrate the portal venous system in a short time [36,37]. However, it uses ionizing radiation and requires a large amount of iodinated contrast material.

Magnetic resonance (MR) angiography is a useful noninvasive method for the assessment of the portal venous system, and it appears to be a more accurate diagnostic procedure than Doppler ultrasonography and CT [38,39].

Venous phase angiography accurately presents the location of the splenic vein obstruction and collateral veins. Diagnosis of splenic vein occlusion is confirmed on angiography when venous collaterals in the splenic hilum and dilated short gastric veins and gastroepiploic veins are seen [40].

The diagnosis of left-sided portal hypertension complicating chronic pancreatitis is based on clinical presentation, preoperative endoscopic and radiographic imaging, and operative findings [13,41], and Evans et al. mentioned that splanchnic angiography is necessary for accurate diagnosis of left-sided portal hypertension [42]. The incidence of left-sided portal hypertension does not correlate to the severity of pancreatitis and may be a result of a mild or subclinical episode of pancreatitis [13,21].

Treatments of Gastric Varices Secondary to Left-sided Portal Hypertension

Several treatment options for gastric variceal bleeding secondary to splenic vein occlusion have been proposed. Splenectomy, which decompresses the short gastric vein by cutting off inflow, has generally been considered the best treatment of choice in such condition [9,11,13,41,42]. Due to the absence of malignant diseases in our patients, splenectomy was a useful treatment for left-sided portal hypertension. However, it is often difficult to determine whether surgical therapy should be undertaken in patients with advanced disease such as pancreatic carcinoma.

Endoscopic injection sclerotherapy (EIS) is more difficult to perform for gastric varices than for esophageal varices, and several reports have demonstrated that EIS of cyanoacrylate is an effective and safe treatment for gastric variceal bleeding [43-45]. Cyanoacrylate polymerizes immediately on contact with blood, resulting in rapid hemostasis. Major complications of the procedure include ulceration and recurrent bleeding, although more serious complications, including embolization to the brain [46], portal vein [47], lung [48,49], and spleen [50,51] have also been reported. Other complications include bacteremia [52] and abscesses [53]. However, it is now the first-choice treatment worldwide for obliteration of bleeding gastric varices. EIS using cyanoacrylate, is useful in the treatment of bleeding gastric varices due to splenic vein occlusion [23,54]. As patients with splenic vein occlusion have normal portal pressure and normal hepatic function, portal systemic shunting is not indicated. Splenic arterial embolization has been used in the treatment of hypersplenism. It is performed by transcatheter deposition of gianturco coils, autologous clots, or absorbable gelatin sponge [55]. Splenic arterial embolization, which reduces blood flow through the splenic parenchyma, is another effective method of controlling bleeding from gastric varices secondary to splenic vein occlusion [13,56-58]. Although this technique can be complicated by pain, splenic abscess or septicemia; splenic arterial embolization is an attractive alternative treatment for gastric varices secondary to splenic vein occlusion in patients at high surgical risk. The role of the splenic arterial embolization should be further analyzed for this condition.

Treatment for this condition should be performed corresponding to the underlying pancreatic diseases. The prognosis of gastric varices secondary to left-sided portal hypertension mainly depends on the underlying pancreatic disease. Most cases of pancreatic carcinoma have a shorter life expectancy and the incidence of gastric variceal bleeding is very low in that short life. When active bleeding is present unresponsive to conservative management, operation or endoscopic therapy should be considered on quickly. There is no consensus on the treatment of asymptomatic patients.

Conclusions

1. ECDUS color flow images of gastric variceal flow clearly depicted round cardiac and fundal regions at the center, with varices expanding to the curvatura ventriculi major of the gastric body as the specific findings of gastric varices secondary to splenic vein occlusion.

2. At present, although there is no consensus on the treatment of gastric varices secondary to splenic vein occlusion, we suggest that it would be directed to the underlying pancreatic diseases.

References

  1. Trudeau W, Prindiville T (1986) Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 32: 264-268.
  2. Cho KC, Patel YD, Wachsberg RH, Seeff J (1995) Varices in portal hypertension: evaluation with CT. Radiographics 15: 609-622.
  3. Sato T, Yamazaki K, Toyota J, Karino Y, Ohmura T, et al. (1999) Evaluation of magnetic resonance angiography in detection of gastric varices. J Gastroenterol 34: 321-326.
  4. Willmann JK, Weishaupt D, Böhm T, Pfammatter T, Seifert B, et al. (2003) Detection of submucosal gastric fundal varices with multi-detector row CT angiography. Gut 52: 886-892.
  5. Marks LJ, Weingarten B, Gerst GR (1952) Carcinoma of the tail of the pancreas associated with bleeding gastric varices and hypersplenism. Ann Intern Med 37: 1077-1084.
  6. Goldstein GB (1972) Splenic vein thrombosis causing gastric varices and bleeding. Am J Gastroenterol 58: 319-325.
  7. Moossa AR, Gadd MA (1985) Isolated splenic vein thrombosis. World J Surg 9: 384-390.
  8. Madsen MS, Petersen TH, Sommer H (1986) Segmental portal hypertension. Ann Surg 204: 72-77.
  9. Sutton JP, Yarborough DY, Richards JT (1970) Isolated splenic vein occlusion. Review of literature and report of an additional case. Arch Surg 100: 623-626.
  10. Babb RR (1976) Editorial: Splenic vein obstruction: a curable cause of variceal bleeding. Am J Dig Dis 21: 512-513.
  11. Muhletaler C, Gerlock AJ Jr, Goncharenko V, Avant GR, Flexner JM (1979) Gastric varices secondary to splenic vein occlusion: radiographic diagnosis and clinical significance. Radiology 132: 593-598.
  12. Ku Y, Kawa Y, Arahi E (1986) Splenic vein occlusion and pancreatic cancer. J Bil Panc 7: 1043-1052.
  13. Sakorafas GH, Sarr MG, Farley DR, Farnell MB (2000) The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg 179: 129-133.
  14. KÃklu S, Yuksel O, Arhan M, Coban S, Basar O, et al. (2005) Report of 24 left-sided portal hypertension cases: a single-center prospective cohort study. Dig Dis Sci 50: 976-982.
  15. Bertina RM (1997) Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 43: 1678-1683.
  16. Koshy A, Jeyakumari M (2006) Factor V Leiden is not commonly associated with idiopathic portal vein thrombosis in southern India. Indian J Gastroenterol 25: 140-142.
  17. Paramythiotis D, Papavramidis TS, Giavroglou K, Potsi S, Girtovitis F, et al. (2010) Massive variceal bleeding secondary to splenic vein thrombosis successfully treated with splenic artery embolization: a case report. J Med Case Rep 4: 139.
  18. Weber SM, Rikkers LF (2003) Splenic vein thrombosis and gastrointestinal bleeding in chronic pancreatitis. World J Surg 27: 1271-1274.
  19. Papavramidis TS, Duros V, Michalopoulos A, Papadopoulos VN, Paramythiotis D, et al. (2009) Intra-abdominal pressure alterations after large pancreatic pseudocyst transcutaneous drainage. BMC Gastroenterol 9: 42.
  20. Papavramidis TS, Kotidis E, Ioannidis K, Cheva A, Lazou T, et al. (2012) The effects of chronically increased intra-abdominal pressure on the rabbit diaphragm. Obes Surg 22: 487-492.
  21. Little AG, Moossa AR (1981) Gastrointestinal hemorrhage from left-sided portal hypertension. An unappreciated complication of pancreatitis. Am J Surg 141: 153-158.
  22. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK (1992) Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16: 1343-1349.
  23. Sato T, Yamazaki K, Akaike J, Toyota J, Karino Y, et al. (2008) Clinical and endoscopic features of gastric varices secondary to splenic vein occlusion. Hepatol Res 38: 1076-1082.
  24. Itzchak Y, Glickman MG (1977) Splenic vein thrombosis in patients with a normal size spleen. Invest Radiol 12: 158-163.
  25. Heider TR, Azeem S, Galanko JA, Behrns KE (2004) The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg 239: 876-880.
  26. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, et al. (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27: 213-218.
  27. Boustière C, Dumas O, Jouffre C, Letard JC, Patouillard B, et al. (1993) Endoscopic ultrasonography classification of gastric varices in patients with cirrhosis. Comparison with endoscopic findings. J Hepatol 19: 268-272.
  28. Caletti GC, Brocchi E, Ferrari A, Fiorino S, Barbara L (1992) Value of endoscopic ultrasonography in the management of portal hypertension. Endoscopy 24: 342-346.
  29. Sanyal AJ (2000) The value of EUS in the management of portal hypertension. Gastrointest Endosc 52: 575-577.
  30. Sato T, Yamazaki K, Toyota J, Karino Y, Ohmura T, et al. (2008) Observation of gastric variceal flow characteristics by endoscopic ultrasonography using color Doppler. Am J Gastroenterol 103: 575-580.
  31. Kohler B, Riemann JF (1999) The role of endoscopic Doppler-sonography. Hepatogastroenterology 46: 732-736.
  32. Sgouros SN, Bergele C, Avgerinos A (2006) Endoscopic ultrasonography in the diagnosis and management of portal hypertension. Where are we next? Dig Liver Dis 38: 289-295.
  33. Sato T (2012) Gastric varices secondary to splenic vein occlusion: endoscopic color Doppler ultrasonography aids diagnosis. J Med Ultrasonics 39: 283-285.
  34. Naik KS, Ward J, Irving HC, Robinson PJ (1997) Comparison of dynamic contrast enhanced MRI and Doppler ultrasound in the pre-operative assessment of the portal venous system. Br J Radiol 70: 43-49.
  35. Capasso P, Dondelinger RF (1998) Vascular disorders of the liver. In: Gazelle GS, Saini S, Mueller PR (eds.). Hepatobiliary and pancreatic radiology: imaging and intervention. 1 st ed. Thieme, New York.
  36. Vogelzang RL, Gore RM, Anschuetz SL, Blei AT (1988) Thrombosis of the splanchnic veins: CT diagnosis. AJR Am J Roentgenol 150: 93-96.
  37. Rahmouni A, Mathieu D, Golli M, Douek P, Anglade MC, et al. (1992) Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis. Gastrointest Radiol 17: 135-140.
  38. Taylor CR, McCauley TR (1992) Magnetic resonance imaging in the evaluation of the portal venous system. J Clin Gastroenterol 14: 268-273.
  39. Finn JP, Kane RA, Edelman RR, Jenkins RL, Lewis WD, et al. (1993) Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography. AJR Am J Roentgenol 161: 989-994.
  40. Illig KA, Spitzer RM, Oates TK (1997) Optimal diagnosis of splenic vein thrombosis: brief clinical report. Am Surg 63: 1005-1006.
  41. Bernades P, Baetz A, Lévy P, Belghiti J, Menu Y, et al. (1992) Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci 37: 340-346.
  42. Evans GR, Yellin AE, Weaver FA, Stain SC (1990) Sinistral (left-sided) portal hypertension. Am Surg 56: 758-763.
  43. Iwase H, Maeda O, Shimada M, Tsuzuki T, Peek RM Jr, et al. (2001) Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding. Gastrointest Endosc 53: 585-592.
  44. Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K (1995) Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 27: 349-354.
  45. Sarin SK, Jain AK, Jain M, Gupta R (2002) A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 97: 1010-1015.
  46. Sée A, Florent C, Lamy P, Lévy VG, Bouvry M (1986) Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients. Gastroenterol Clin Biol 10: 604-607.
  47. Mostafa I, Omar MM, Nouh A (1997) Endoscopic control of gastric variceal bleeding with butyl cyanoacrylate in patients with schistosomiasis. J Egypt Soc Parasitol 27: 405-410.
  48. Roesch W, Rexroth G (1998) Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 30: S89-90.
  49. Hwang SS, Kim HH, Park SH, Kim SE, Jung JI, et al. (2001) N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. J Comput Assist Tomogr 25: 16-22.
  50. Tan YM, Goh KL, Kamarulzaman A, Tan PS, Ranjeev P, et al. (2002) Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc 55: 276-278.
  51. Cheng PN, Sheu BS, Chen CY, Chang TT, Lin XZ (1998) Splenic infarction after histoacryl injection for bleeding gastric varices. Gastrointest Endosc 48: 426-427.
  52. Chen WC, Hou MC, Lin HC, Yu KW, Lee FY, et al. (2001) Bacteremia after endoscopic injection of N-butyl-2-cyanoacrylate for gastric variceal bleeding. Gastrointest Endosc 54: 214-218.
  53. Verger P, Blais J, Gruau M, Haffaf Y (1998) Retrogastric abscess secondary to gastric varices obturation with cyanoacrylate. Gastroenterol Clin Biol 22: 248-249.
  54. Sato T, Aso K, Higashino K, Kato S, Toyota J, et al. (1996) Gastric varices due to splenic vein occlusion with left renal cell carcinoma. Dig Endosc 8: 166-169.
  55. Adams DB, Mauterer DJ, Vujic IJ, Anderson MC (1990) Preoperative control of splenic artery inflow in patients with splenic venous occlusion. South Med J 83: 1021-1024.
  56. McDermott VG, England RE, Newman GE (1995) Case report: bleeding gastric varices secondary to splenic vein thrombosis successfully treated by splenic artery embolization. Br J Radiol 68: 928-930.
  57. Sato T, Yamazaki K, Toyota J, Karino Y, Ohmura T, et al. (2000) Gastric varices with splenic vein occlusion treated by splenic arterial embolization. J Gastroenterol 35: 290-295.
  58. Cakmak O, Parildar M, Oran I, Sever A, Memis A (2005) Sinistral portal hypertension; imaging findings and endovascular therapy. Abdom Imaging 30: 208-213.
Citation: Sato T, Kitagawa S, Kimura M, Ohmura T, Karino Y, et al. (2013) Gastric Varices Secondary to Splenic Vein Occlusion due to Pancreatic Diseases. Pancreatic Dis Ther S3:001.

Copyright: © 2013 Sato T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top